Hi everybody, welcome back to synthetic biology one. In this series, we present different opinions on the GMO debate. I know that you all have opinions on this, but try to leave them aside for now. Instead, focus on three questions that will help us to understand the many different sides of the debate and how they interact.
Today’s opinion comes from Jason Kelly, a co-founder and CEO of Ginkgo Bioworks. Gingko is a metabolic engineering company based in Boston, USA. Full disclosure: Jason is also my friend. But that doesn’t mean I’m going to go easy on him or his opinions. I’ll be reading highlights from a opinion piece he wrote for the New York Times.